Global Bioenergies signs a first contract with an American industrial group and validates its commercial strategy


Munich, December 14, 2010 – Global Bioenergies, based near Paris (France) and having recently opened an office in Munich (Germany), announces a first agreement with an American partner concerning a specific application of its gaseous hydrocarbon bioproduction process. This partnership validates the commercial strategy put in place by the company, based on the establishment of application-specific licensing agreements. Next


pdf

Global Bioenergies succeeds in creating a bacterial prototype that produces isobutene from glucose


Evry, October 6, 2010 - Global Bioenergies, located on the Genopole campus at Evry (France), announces the first prototype of its manufacturing process for the biological production of isobutene. It relies on the use of a bacterial strain harboring an artificial metabolic pathway created by the company. Next


pdf

Global Bioenergies is granted $1.1 million to accelerate the development of isobutene bioproduction


EVRY, 2nd February 2010 - Global Bioenergies, located on the Genopole campus at Evry (France), has received €760,000 ($1.1m) in funding from the French innovation agency OSEO to accelerate the development of its process for converting renewable resources into isobutene, a gas that can be transformed into liquid fuels and diverse polymers. This funding will allow the company to take on new staff, move to larger facilities and take a step towards the industrialization of this bioprocess. Next


pdf